Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.54 |
| ▸ | TOP1 | P11387 | 3/20 | 0.53 |
| ▸ | CYCS | P99999 | 4/20 | 0.52 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | HPGD | P15428 | 3/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | TERT | O14746 | 1/20 | 0.45 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.43 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8994447 | 0.93 | TOP1 (0.60) | ABCG2TOP1CYCSENPP2SMN1; SMN2 | |
| SCHEMBL9910535 | 0.91 | ABCG2 (0.55) | ABCG2TOP1CYCSENPP2SMN1; SMN2 | |
| SCHEMBL7241022 | 0.87 | TOP1 (0.58) | ABCG2TOP1CYCSENPP2SMN1; SMN2 | |
| SCHEMBL1974241 | 0.84 | TOP1 (0.68) | ABCG2TOP1CYCSENPP2SMN1; SMN2 | |
| SCHEMBL7265156 | 0.84 | MTNR1A (0.53) | ABCG2TOP1CYCSENPP2SMN1; SMN2 | |
| SCHEMBL7239829 | 0.84 | ALDH1A1 (0.54) | ABCG2TOP1CYCSENPP2SMN1; SMN2 | |
| SCHEMBL8865129 | 0.81 | KMT2A (0.55) | ABCG2TOP1CYCSSMN1; SMN2KDM4E | |
| SCHEMBL22461492 | 0.79 | TERT (0.58) | ABCG2TOP1CYCSENPP2TERT | |
| SCHEMBL22461493 | 0.79 | TERT (0.58) | ABCG2TOP1CYCSENPP2TERT | |
| SCHEMBL22461491 | 0.79 | TERT (0.58) | ABCG2TOP1CYCSENPP2TERT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8436242-B2 | Photocharge separation using supramolecular complex of π-electron type extended viologen derivative and porphyrin | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2013-05-07 | — | — | US | disclosed |
| US-20080202578-A1 | Photocharge Separation Using Supramolecular Complex of Ii-Electron Type Extended Viologen Derivative And Porphyrin | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2008-08-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080202578-A1 | Photocharge Separation Using Supramolecular Complex of Ii-Electron Type Extended Viologen Derivative And Porphyrin | PPOX, PPIG, CRY2 | ABCG2 2576/4885TOP1 527/4885CYCS 39/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.